中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | N,N'-dibutyryl-urea | 873972-66-8 | C9H16N2O3 | 200.238 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | N,N'-dibutyryl-urea | 873972-66-8 | C9H16N2O3 | 200.238 |
(4CI)-1-乙酰基-3-丁基脲 | N-acetyl-N'-butyryl-urea | 873972-81-7 | C7H12N2O3 | 172.184 |
To examine experiences of medicine use, advice and support from the perspectives of people taking medicines long term for arthritis, respiratory disease and mental health problems.
Twelve group interviews were conducted, four with each of the three chronic illness groups.
Interviews were arranged through national and local voluntary organisations and conducted as part of their regular meetings.
The most prominent issue for all the Arthritis Care groups was information about side effects. People discussed the benefits of having this information and the reasons they believed that it was not generally provided. People with respiratory disease described difficulties of obtaining information as a problem in the operation of the health service in Britain, where participants may or may not find out about different products by chance. In all these discussions there were examples of how people used their regular group meetings to inform each other. For people with mental health problems, participation in decisions concerning medicines and the attitudes of health professionals were the most prominent issues. Members of all groups, across all chronic illnesses, claimed that adequate information was not shared with them during consultations with professionals. However, different perspectives of involvement in decision-making regarding therapy were distinguishable. Pharmacy services did not feature prominently in any of the group discussions.
The study revealed differences between the illness groups in the emphasis participants placed on different issues. However, there were also common concerns, in particular relating to obtaining information and the attitudes of professionals. While pharmacy services were not prominent in discussions, a range of unmet needs concerning medicines were identified. This indicates that opportunities exist for pharmacists to provide more responsive services that would be valued by people taking long-term medication.
从长期服用药物治疗关节炎、呼吸道疾病和心理健康问题的人的角度,探讨药物使用经验、建议和支持。
进行了十二次小组访谈,每种慢性疾病群体各四次。
通过国家和当地志愿组织安排了访谈,并作为他们定期会议的一部分进行。
对于所有关节炎护理小组来说,最突出的问题是有关副作用的信息。人们讨论了获得这些信息的好处以及他们认为通常不提供这些信息的原因。患有呼吸道疾病的人描述了在英国卫生服务运作中获得信息的困难,参与者可能或可能不会偶然发现不同产品的情况。在所有这些讨论中,都有人们如何利用定期小组会议相互通知的例子。对于患有心理健康问题的人来说,参与药物决策和卫生专业人员的态度是最突出的问题。所有慢性疾病群体的成员声称在与专业人员的咨询中未能分享足够的信息。然而,在治疗决策方面有不同的参与观点。药房服务在任何小组讨论中都没有显著特色。
研究揭示了患病群体在强调不同问题方面的差异。然而,也存在共同的关注点,特别是有关获取信息和专业人员态度的问题。虽然药房服务在讨论中并不突出,但发现了有关药物的一系列未满足需求。这表明药剂师有机会提供更加贴心的服务,这将受到长期服药的人们的重视。